REQUEST A DEMO
Total
USD $0.00
Search more companies

Novabridge Biosciences (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novabridge Biosciences Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Novabridge Biosciences is an enterprise in China, with the main office in Shanghai. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on April 01, 2026. It currently has a total number of 32 (2024) employees. Over the same period, its total assets grew by 747.14%.

Headquarters
Suite 802, West Tower, Omnivision, 88 Shangke Road, Pudong District
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Novabridge Biosciences report to view the information.

Website: http://www.i-mabbiopharma.com

Basic Information
Total Employees:
Purchase the Novabridge Biosciences report to view the information.
Outstanding Shares:
Purchase the Novabridge Biosciences report to view the information.
Financial Auditors:
Purchase the Novabridge Biosciences report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
17.9%
Purchase this report to view the information.
15.7%
Purchase this report to view the information.
10%
Purchase this report to view the information.
7.3%
Purchase this report to view the information.
5.1%
Subsidiaries
Chengdu Tasgen Bio-Tech Co., Ltd.
I-Mab Bio-Tech (Tianjin) Co., Ltd.
I-Mab Biopharma (Shanghai) Co., Ltd.
Company Performance
Financial values in the chart are available after Novabridge Biosciences report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Operating Profit
-245.72%
EBITDA
-290.64%
Net Profit/Loss for the Period
-742.31%
Total Assets
747.14%
Total Equity
744.36%
Return on Equity (ROE)
0.06%
Quick Ratio
87642.49%
Cash Ratio
7.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?